00000nam 2200000zi 4500 9.951396 CaOODSP 20250828135915 m o d f cr mn||||||||| 250527e202506##onc ob f000 0 eng d 9780660774299 CaOODSP eng rda CaOODSP n-cn--- H164-394/2025E-PDF Guidance document on submission information for biologic drugs (Division 4, Schedule D). Health Canada guidance document : biologic drugs Ottawa, ON : Health Canada = Santé Canada, June 2025. ©2025 1 online resource (ii, 35 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Ligne directrice sur les informations à soumettre pour les médicaments biologiques (titre 4, annexe D). Title from cover. "Date: 2025-06." "Pub.: 250073"--Verso of cover. Includes bibliographical references. Biologicals Government policy Canada. Pharmaceutical industry Government policy Canada. Biologicals Law and legislation Canada. Drugs Law and legislation Canada. Canada. Health Canada, issuing body. Ligne directrice sur les informations à soumettre pour les médicaments biologiques (titre 4, annexe D). (CaOODSP)9.951397 PDF 696 KB https://publications.gc.ca/collections/collection_2025/sc-hc/H164-394-2025-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-information-biologic-drugs-division-4-schedule-d.html 250073